Cerebral infarction and Coronary heart disease
Conditions
Interventions
Case series:Danhong injection
Sponsors
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Comply with the diagnosis of cerebral infarction (acute phase or recovery) or coronary heart disease angina pectoris; 2. Meet the indications of Danhong injection and users; 3. Once the patient begins selected, the patients who use Danhong injections must be continuously enrolled , can not pick selected object, also can not drain option selected object until completion of pre-designed cases.
Exclusion criteria
Exclusion criteria: 1. Estimated survival time less than one month; 2. Ultra manual medication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The 14 days ending of Clinical practice of Danhong injection in the treatment of cerebral infarction;The 3-6 months ending (mortality, recurrence, morbidity) of clinical practice of Danhong injection in the treatment of cerebral infarction;The recent curative effect (pain relief time and the number of angina attacks) of Clinical practice of Danhong injection in the treatment of Coronary heart disease angina pectoris;Efficacy (cardiovascular and cerebrovascular events, attack frequency of angina pectoris) of Clinical practice of Danhong injection in the treatment of coronary heart disease angina pectoris; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total mortality;The symptoms and curative effect of traditional Chinese medicine;Changes in clinical symptoms and signs;Patient satisfaction; | — |
Countries
China
Contacts
Public ContactWu Shengxian
Outcome results
None listed